RTW Biotech Opportunities (LON:RTW – Get Free Report) rose 3.2% during mid-day trading on Wednesday . The stock traded as high as GBX 2.23 and last traded at GBX 2.23. Approximately 1,673,508 shares changed hands during trading, an increase of 189% from the average daily volume of 578,905 shares. The stock had previously closed at GBX 2.16.
RTW Biotech Opportunities Stock Performance
The stock has a market cap of £7.28 million, a P/E ratio of -0.09 and a beta of 0.60. The stock’s fifty day moving average is GBX 2.07 and its 200 day moving average is GBX 1.69.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
See Also
- Five stocks we like better than RTW Biotech Opportunities
- A month before the crash
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Bitcoin is down but your income is about to explode
- Trump Devises the Death of the IRS ☠️
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
